Sartorius (SARTF) Lowered to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of Sartorius (OTCMKTS:SARTF) from a hold rating to a sell rating in a report published on Tuesday.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Shares of Sartorius stock opened at $109.50 on Tuesday. Sartorius has a 52 week low of $109.50 and a 52 week high of $149.00. The company has a current ratio of 1.62, a quick ratio of 1.00 and a debt-to-equity ratio of 1.08.
Sartorius Company Profile
There is no company description available for Sartorius AG.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.